Technical analysis of Edesa Biotech, Inc. (EDSA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate.
Price Performance
| 1 month | -32.22% |
| 3 months | -47.35% |
| Year-to-date | +172.54% |
| 1 year | +61.92% |
| 3 years | -36.45% |
| 5 years | -90.60% |
52-Week Range
| 52-week High | $20.32 |
| 52-week Low | $0.72 |
| Avg Volume (90d) | 155K |
Technical Indicators
| SMA 50 | $5.32 |
| SMA 200 | $5.37 |
| Beta | -0.68 |
| 30-day Volatility (annualised) | 82.1% |
| Price vs SMA 50 | -27.3% |
| Price vs SMA 200 | -28.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.86 | |
| 2025-11 | $1.75 | -5.9% |
| 2025-12 | $1.42 | -18.9% |
| 2026-01 | $1.17 | -17.6% |
| 2026-02 | $2.20 | +88.0% |
| 2026-03 | $5.23 | +137.7% |
| 2026-04 | $18.27 | +249.3% |
| 2026-05 | $7.22 | -60.5% |
| 2026-06 | $8.13 | +12.6% |
| 2026-07 | $5.11 | -37.1% |
| 2026-08 | $4.74 | -7.2% |
| 2026-09 | $3.87 | -18.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $3.87 |
| Market Cap | $37M |
| Exchange | NASDAQ |
| Country | CA |
Valuation Ratios
| Price / Book | 3.96 |
| EV / EBITDA | -2.46 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 2.76 |